Ming Ge

Dr. Ming Ge

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
XSXudong Shen
Xudong Shen
ZTZequn Tang
Zequn Tang
YBYu Bai
Yu Bai
MWMeishuo Wan
Meishuo Wan
MYMiao Yu
Miao Yu
MGMing Ge
Ming Ge

20 June 2019 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
XTXiangqi Teng
Xiangqi Teng
WZWeiqian Zhang
Weiqian Zhang
YSYangyang Song
Yangyang Song
HWHaibin Wang
Haibin Wang
MGMing Ge
Ming Ge
RZRuili Zhang
Ruili Zhang

10 January 2019 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
RLRuyue Li
Ruyue Li
LZLinan Zhang
Linan Zhang
ZTZequn Tang
Zequn Tang
TLTianqi Li
Tianqi Li
GLGuangxing Li
Guangxing Li
MGMing Ge
Ming Ge

1 July 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
CHChun-Lei Han
Chun-Lei Han
YLYun-Peng Liu
Yun-Peng Liu
XZXue-Min Zhao
Xue-Min Zhao
KWKai-Liang Wang
Kai-Liang Wang
NCNing Chen
Ning Chen
FMFan-Gang Meng
Fan-Gang Meng

6 November 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
YMYuqi Miao
Yuqi Miao
KFKaiyu Fan
Kaiyu Fan
XPXiaojiao Peng
Xiaojiao Peng
SLSi Li
Si Li
JCJiahui Chen
Jiahui Chen
DWDi Wu
Di Wu
Objective: Hypothalamic-pituitary axis dysfunction is a common complication in post-operative craniopharyngioma(CP) patients, and it greatly impacts the long-term quality of life of such patients. To better understand the effects of postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement therapy in patients with childhood CP, we assessed approximately 200 patients with childhood-onset CP postoperatively.Methods: Clinical details of patients with childhood-onset CP who underwent sellar tumor resection in Beijing Children’s Hospital and Beijing Tiantan Hospital from 2018 to 2019 were retrieved retrospectively. The participants were followed up to assess the effects of post-operative long-term hormone replacement therapy and assess the tumor recurrence rate.Results: The median age of admission was 8.1 (1.8, 14.3) years. Headache (45.5%), visual impairment (39.5%), and nausea (33.0%) were the most common clinical manifestations. ACP accounted for 95% of all CP cases. The incidence of central adrenal insufficiency and central hypothyroidism within the first week after surgery was 56.2% and 70.3%, respectively. At the same time 85.5% of the patients required at least one dose of desmopressin to control urine output. Total survival and tumor recurrence rates were 98.6% and 26.1%, respectively, with a median follow-up time of 29.7 (19.0, 40.3) months. During the follow-up period, 28.1% patients met the diagnostic criteria for short stature, while 54.4% fit the criteria for obesity. In addition, 94.4% of the patients were taking at least one kind of hormone substitution, and 74.7% were taking three or more. The prevalence of levothyroxine, glucocorticoid, desmopressin, and growth hormone replacement therapy was 87.3%, 77.5%, 78.9% and 31.0%, respectively. The proportion of patients treated with the substitutive combination of levothyroxine, hydrocortisone, and desmopressin was 54.9%.Conclusion: This study is a large-sample systematic postoperative endocrine function evaluation of patients with childhood-onset CP. Due to the high prevalence of post-operative hypothalamic-pituitary dysfunction, patients with CP usually require long-term multiple hormone substitution therapy. Individualized management and accurate hormone replacement dosage for postoperative childhood-onset CP patients are of great importance.

27 January 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
WYWei Yang
Wei Yang
YCYingjie Cai
Yingjie Cai
JCJiashu Chen
Jiashu Chen
PYPing Yang
Ping Yang
ZYZesheng Ying
Zesheng Ying
MGMing Ge
Ming Ge
Background: We aimed to describe the epidemiological characteristics, clinical presentations, and prognoses in a national health center for children.Methods: From January 2015 to December 2020, 484 patients aged 0-16 years, who were diagnosed with brain tumors and received neurosurgery treatment, were enrolled in the study. Pathology was based on the World Health Organization 2021 nervous system tumor classification, and tumor behaviors were classified according to the International Classification of Diseases for Oncology, third edition.Results: Among the 484 patients with brain tumors, the median age at diagnosis was 4.62 [2.19, 8.17] years (benign tumors 4.07 [1.64, 7.13] vs. malignant tumors 5.36 [2.78, 8.84], p=0.008). The overall male-to-female ratio was 1.33:1(benign 1.09:1 vs. malignant 1.62:1, p=0.029). Nausea, vomiting, and headache were the most frequent initial symptoms. The three most frequent tumor types were embryonal tumors (ET, 22.8%), circumscribed astrocytic gliomas (20.0%), and pediatric-type diffuse gliomas (11.0%). The most common tumor locations were the cerebellum and fourth ventricle (38.67%), the sellar region (22.9%) and ventricles (10.6%). Males took up a higher proportion than females in choroid plexus tumors (63.6%), ET (61.1%), ependymal tumors (68.6%), and germ cell tumors (GCTs, 78.1%). Patients were followed for 1 to 82 months. The overall 5-year survival rate was 77.5%, with survival rates of 91.0% for benign tumors and 64.6% for malignant tumors.Conclusion: Brain tumors presented particularly sex-, age-, and regional-dependent epidemiological characteristics. Our results were consistent with previous reports and might reflect the real epidemiological status in China.